Stay updated on Efgartigimod in ITP Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in ITP Clinical Trial page.

Latest updates to the Efgartigimod in ITP Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision label 'Revision: v3.4.2' was added to the history, and an earlier government funding notice was removed. These are administrative site maintenance changes and do not affect study data, eligibility, or any user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check25 days agoChange DetectedNotice added: due to a lapse in government funding, the page may not be up to date and transactions may be delayed. Revision updated to v3.4.1, replacing v3.4.0.SummaryDifference0.6%

- Check32 days agoChange DetectedThe history view adds a glossary toggle and color-coded diffs (green for additions, red for deletions), updates the revision banner to v3.4.0, and removes the 'No FEAR Act Data' note.SummaryDifference0.7%

- Check46 days agoChange DetectedThe page history now shows an added Revision: v3.3.4 and a removed Revision: v3.3.3, indicating a minor maintenance update to the release notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe version history now includes a new revision tag: Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed from the page footer, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check96 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. No changes to study data or navigation are evident.SummaryDifference0.1%

Stay in the know with updates to Efgartigimod in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in ITP Clinical Trial page.